Immunostaining of human brain sections of AD patients also revealed both intra-neuronal and global elevation of Aβ, CHMP2B and Galectin-3 immunoreactivity colocalizing with LAMP2, compared with healthy control (HC) individuals (Fig.4c, and Extended Data Fig.11a-d). The gene discussed is LAMP2; the disease is Alzheimer disease.